the aid library

LIST OPTIONS

Filter

13752

Sort by:

Direction:

Download (273)

View PDF (368)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (234)

View PDF (215)

Infection prevention and control in the context of coronavirus disease (‎COVID-19)‎: a living guideline, 9 October 2023

World Health Organization WHO (2023) CC

The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline... more

Download (128)

View PDF (139)

World Disasters Report 2022: Executive Summary

International Federation of Red Cross and Red Crescent Societies IFR (2023) CC

The COVID-19 pandemic has been the biggest disaster in living memory, on almost any measure. More than 6.5 million people are confirmed to have died in less than three years, and the pandemic’s indirect impacts have touched the lives of virtually every community on the planet. Our World Disasters... more

Download (156)

View PDF (133)

Communicating about Vaccination-related Risks

World Health Organisation (WHO) (2023) C_WHO

This document seeks to help health communication professionals working on the topic of immunization more effectively communicate about Events Supposedly Attributed to Vaccination and Immunization (ESAVI) by building trust in National Immunization Programs, understanding risk perceptions related to v... more

Download (160)

View PDF (167)

Research gaps and needs to optimize the use of assisted vaginal birth: technical brief

World Health Organisation (WHO) (2023) C_WHO

Lack of trained providers capable of identifying which labouring women could benefit from assisted vaginal birth (AVB), and of safely performing the procedure is a major barrier for its use. Education and training are, therefore, considered crucial for building skills and confidence in conducting AV... more

Download (179)

View PDF (110)

WHO Tanzania 2022 Annual Report

World Health Organisation (WHO) (2023) C_WHO

The Annual Report summarizes what has been achieved in the year 2022, how WHO supported the country priority, how WHO took the lead in health in bringing together partners to help the country achieve its strategic goals as a result be on track on its commitment on the SDG goals. The report also high... more

Download (150)

View PDF (178)

PAHO’s Health Emergency Appeal 2023

World Health Organisation (WHO) (2023) C_WHO

This document outlines PAHO’s regional priorities for the year 2023 to sustain and scale up health emergency and humanitarian assistance in the Americas, with a focus on five priority countries currently facing a prolonged humanitarian crisis and recovering from recent acute emergencies: Colombia,... more

Download (180)

View PDF (217)

EASO Special Report: Asylum Trends and COVID-19, Issue 2 (11 June 2020)

European Asylum Support Office (2020) CC

Only 8,730 asylum applications were registered in the EU+ in April, the lowest since at least 2008, and a massive 87% decrease from pre-COVID-19 levels in January and February. The European Asylum Support Office (EASO) has released a special report which shows that the COVID-19 related travel restr... more

Download (270)

View PDF (486)

International Standards of Drug Use Prevention

World Health Organization (WHO); United Nations Office on Drug and Crime UNODC (2019) C_WHO

2nd revised edition. Accessed Apri. 17, 2019 Prevention strategies based on scientific evidence working with families, schools, and communities can ensure that children and youth, especially the most marginalized and poor, grow and stay healthy and safe into adulthood and old age. For every dollar ... more

Download (115)

View PDF (137)

WHO's Response to the Ukraine Crisis. Interim Report. February to June 2022

World Health Organization (WHO) (2022) C_WHO

The military offensive by the Russian Federation in Ukraine which began February 2022 has triggered one of the world’s fastest-growing displacement and humanitarian crisis, with geopolitical and economic ripples felt across the globe. The ongoing war has caused large-scale disruptions to the deliv... more

Download (125)

View PDF (840)

Guidance Note: Qualitative Assessment Approaches for the Protection of Children with Disabilities Within Humanitarian Contexts

The Alliance for Child Protection in Humanitarian Action (2023) C1

Children with disabilities are particularly vulnerable in humanitarian settings, yet they are often not able to access the services and protection they need. While multiple factors create these barriers, a major cause is how data about children with disabilities is collected and mapped. Data collect... more

Download (254)

View PDF (255)

Essential care and practice mhGAP Training of Health-care Providers. Training manual and supporting material

World Health Organization (WHO) (2015) C_WHO

Key messages include Effective communication skills should be used for everyone seeking health care, including people with MNS conditions and their carers; Effective communication skills enable health-care providers to build rapport and trust with people as well as enabling health-care providers to... more

Download (329)

View PDF (478)

Dementia mhGAP module
recommended

World Health Organization WHO (2017) C_WHO

DEM supporting material • Person stories • Role plays • Case scenarios • Treatment planning handouts • Treatment planning suggestions • Multiple choice questions • Video link Activity 3: mhGAP DEM module – assessment

Download (128)

View PDF (344)

Report of a global meeting on yaws eradication surveillance, monitoring and evaluation: Geneva, 29–30 January 2018

World Health Organization WHO; Institutional research information sharing iris (2018) C_WHO

Report of a global meeting on yaws eradication surveillance, monitoring and evaluation: Geneva, 29–30 January 2018. World Health Organization.

Download (132)

View PDF (906)

Guide to Prudent Use of Antimicrobial Agents in Dairy Production

International Dairy Federation (2013) C2

Antimicrobial agents play an indispensable role in animal health and welfare management. At the same time, the need for prudent use is obvious to ensure good food safety outcomes and to manage the potential risk of antimicrobial resistance. The emergence of multi-resistant bacteria is posing challen... more

Download (156)

View PDF (187)

Drugs to prevent COVID-19: living guideline

World Health Organisation (WHO) (2023) C_WHO

The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform. Guidelines ... more

Download (125)

View PDF (164)

WHO's response to the Ukraine crisis

World Health Organisation (WHO) (2023) C_WHO

Since 24 February 2022, the war in Ukraine has caused widespread suffering to its people and serious damage to the country’s infrastructure. Attacks on the country’s health system and its power network threaten people, compromise the provision of health care, and complicate the distribution of ... more

Download (106)

View PDF (442)

A toolkit for national dengue burden estimation

Brady, O. J. et all. WHO (2018) CC

The aim of this toolkit is to guide countries on how to best estimate their current burden of dengue by combining existing data from dengue surveillance systems with on-going research efforts to measure the community burden of dengue.

Download (203)

View PDF (157)

The conflict in Ukraine and its impact on organized crime and security - November 2022

UN Interregional Crime and Justice Research Institute UNICRI Reliefweb OCHA Services (2022) C2

This report assesses the impact of the conflict in Ukraine and its implications for organized crime and security-related issues for neighbouring countries, with a focus on Moldova. These include: Organized crime and illicit trafficking (including trafficking in persons, drugs, arms, illicit toba... more

Download (1873)

View PDF (1680)

La prévention de l’hémorragie du post-partum : La gestion active de la troisième période de l’accouchement - Formation d’accoucheurs qualifiés : Manuel de Référence

Initiative pour la Prévention de l’Hémorragie du Post-partum (POPPHI) Program for Appropriate Technology in Health (PATH) (2008) C1

Manuel de référence pour les accoucheurs qualifiés

Dementia mhGAP module recommended

Dementia mhGAP module
recommended